Evidence map›Paper›PMID 9456313›Full record

ArticleThe Journal of cell biology1998

Cell-free transport to distinct Golgi cisternae is compartment specific and ARF independent.

S Happe, P Weidman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S HappeDepartment of Biochemistry and Molecular Biology, St. Louis University School of Medicine, St. Louis, Missouri 63104, USA.
P Weidman
Saint Louis University · US

Funding

ELUCIDATION OF THE MECHANISMS--IN VITRO GOLGI TRANSPORTR01GM054428 · NIGMS · SAINT LOUIS UNIVERSITY · PI WEIDMAN, MARGARET J · 1996 to 1999
–
MULTIDISCIPLINARY LUNG DISEASE RESEARCH TRAINING PROGRAMT32HL007050 · NHLBI · SAINT LOUIS UNIVERSITY · PI LONGMORE, WILLIAM J · 1985 to 1995
–
NHLBI NIH HHS HL07050NIGMS NIH HHS GM54428
6 · The paper itself

Abstract

The small GTPase ADP-ribosylation factor (ARF) is absolutely required for coatomer vesicle formation on Golgi membranes but not for anterograde transport to the medial-Golgi in a mammalian in vitro transport system. This might indicate that the in vivo mechanism of intra-Golgi transport is not faithfully reproduced in vitro, or that intra-Golgi transport occurs by a nonvesicular mechanism. As one approach to distinguishing between these possibilities, we have characterized two additional cell-free systems that reconstitute transport to the trans-Golgi (trans assay) and trans-Golgi network (TGN assay). Like in vitro transport to the medial-Golgi (medial assay), transport to the trans-Golgi and TGN requires cytosol, ATP, and N-ethylmaleimide-sensitive fusion protein (NSF). However, each assay has its own distinct characteristics of transport. The kinetics of transport to late compartments are slower, and less cytosol is needed for guanosine-5'-O-(3-thiotriphosphate) (GTPgammaS) to inhibit transport, suggesting that each assay reconstitutes a distinct transport event. Depletion of ARF from cytosol abolishes vesicle formation and inhibition by GTPgammaS, but transport in all assays is otherwise unaffected. Purified recombinant myristoylated ARF1 restores inhibition by GTPgammaS, indicating that the GTP-sensitive component in all assays is ARF. We also show that asymmetry in donor and acceptor membrane properties in the medial assay is a unique feature of this assay that is unrelated to the production of vesicles. These findings demonstrate that characteristics specific to transport between different Golgi compartments are reconstituted in the cell-free system and that vesicle formation is not required for in vitro transport at any level of the stack.

Indexed as

Membrane GlycoproteinsVesicular Transport ProteinsAcetylglucosamineAdenosine TriphosphateADP-Ribosylation Factor 1ADP-Ribosylation FactorsAnimalsBiological TransportCarrier ProteinsCell-Free SystemCHO CellsCoated VesiclesCricetinaeCytosolGalactoseGolgi ApparatusAcetylglucosamineAdenosine TriphosphateADP-Ribosylation Factor 1ADP-Ribosylation FactorsCarrier ProteinsGalactoseG protein, vesicular stomatitis virusGTP-Binding ProteinsGuanosine 5'-O-(3-Thiotriphosphate)Membrane GlycoproteinsN-Ethylmaleimide-Sensitive ProteinsRecombinant ProteinsUridine Diphosphate GalactoseVesicular Transport ProteinsViral Envelope Proteins

Identifiers

PMID9456313
PMCPMC2140162
OpenAlexW1971278339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.